New Research Challenges BMI Guidelines: Overweight Older Adults Show Lower Post-Surgery Mortality Risk

Emerging evidence suggests that overweight seniors may have a lower risk of early death after major surgery, challenging traditional BMI guidelines for older adults.
Recent research indicates that older adults who are classified as overweight may have a lower risk of mortality within the first 30 days after major elective surgery compared to those with normal or underweight BMI levels. Published in JAMA Network Open, the study analyzed data from 414 seniors undergoing significant surgeries at a major Southern California medical center between February 2019 and January 2022. Findings revealed that individuals with a BMI between 25 and 29.9, considered overweight, experienced a remarkably low 0.8% 30-day mortality rate, whereas normal-weight patients faced an 18.8% rate, and underweight patients experienced a 15% rate. Even after adjusting for variables like age, frailty, and health conditions such as cancer, the trend persisted. This phenomenon supports the concept of the 'obesity paradox,' suggesting that in older populations, a slightly higher BMI might offer protective benefits in the short-term postoperative period.
Lead researcher Dr. Cecilia Canales from UCLA emphasized that traditional surgical guidelines, which favor a normal BMI prior to surgery, may need revision for the elderly, considering unique physiological changes with age. Dr. Catherine Sarkisian, another expert involved in the study, noted that these findings could influence preoperative assessments and risk evaluations, which are typically based on data from younger or mixed-age groups. The study underscores the importance of personalized evaluation in surgical planning for older adults and advocates for further research into the underlying biological mechanisms of this association.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Airborne Fungal Spores as Predictors of COVID-19 and Flu Outbreaks
Monitoring airborne fungal spores can help predict COVID-19 and flu outbreaks, offering a valuable tool for early warning and better public health preparedness.
Utilizing Eye Tracking Metrics to Detect Concussion-Related Visual Disorders
Innovative eye-tracking technology offers promising advancements in diagnosing concussion-related visual disorders, enabling early intervention and improved recovery outcomes.
FDA Approves First Medication for Chronic Lung Disease Bronchiectasis
The FDA has approved Brinsupri, the first medication specifically targeting non-cystic fibrosis bronchiectasis, offering new hope for patients with this chronic lung condition.
Breakthrough in Cancer Therapy: CAR T Cells Target Solid Tumors
Innovative CAR T cell therapy is making strides in targeting solid tumors like ovarian and breast cancer, promising new treatment options beyond blood cancers. Researchers are optimizing manufacturing processes to broaden access and improve outcomes.



